Remus Pharmaceuticals Limited (NSE:REMUS)
India
· Delayed Price · Currency is INR 699.80
+41.80 (6.35%)
Apr 29, 2026, 3:29 PM IST
Remus Pharmaceuticals Market Cap
Remus Pharmaceuticals has a market cap or net worth of 7.67 billion as of April 29, 2026. Its market cap has decreased by -41.95% in one year.
Market Cap
7.67B
Enterprise Value
7.93B
Revenue
7.48B
Ranking
n/a
PE Ratio
24.04
Stock Price
699.80
Market Cap Chart
Since May 29, 2023, Remus Pharmaceuticals's market cap has increased from 2.65B to 7.67B, an increase of 189.83%. That is a compound annual growth rate of 44.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 7.67B | -6.29% |
| Dec 31, 2025 | 8.19B | -44.37% |
| Dec 31, 2024 | 14.72B | 30.53% |
| Dec 29, 2023 | 11.27B | 325.95% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Accent Microcell | 9.17B |
| Infinium Pharmachem | 3.27B |
| Quest Laboratories | 2.06B |
| Sotac Pharmaceuticals | 1.29B |
| Zenith Drugs | 741.69M |
| Vilin Bio Med | 511.97M |
| Medicamen Organics | 341.64M |
| Sunrest Lifescience | 157.92M |